Trends Endocrinol Metab. 2008 May-Jun;19(4):113-21. Epub 2008 Mar 20.

Do the cholesterol-lowering properties of statins affect cancer risk?

Source

Department of Orthopaedic Surgery, Children's Hospital Boston, Boston, MA 02115, USA. keith.solomon@childrens.harvard.edu

Abstract

The potential of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors ('statins') to reduce the incidence and/or progression of certain malignancies remains uncertain. Some investigators have concluded that statins have no effects on malignancies of any kind. However, results of several epidemiologic studies, including four recent prospective cohort studies, suggest that long-term statin therapy inhibits the progression of prostate cancer. We argue that the principal mechanism of any anticancer effects from statin use arises from prolonged lowering of circulating cholesterol. Evidence suggests that prostate cancer might be particularly sensitive to this intervention. Our hypothesis provides a perspective from which mechanistic studies of cholesterol-lowering drugs and cancer, in addition to prospective trials in patients, might be designed.

PMID:: 18356074; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

CHOLESTEROL - HSDB

Supplemental Content

Save items

Related citations in PubMed

Review A clinical review of statins and cancer: helpful or harmful? [Pharmacotherapy. 2010]
Review A clinical review of statins and cancer: helpful or harmful?
Gonyeau MJ, Yuen DW. Pharmacotherapy. 2010 Feb; 30(2):177-94.
Review Statins and breast cancer: may matrix metalloproteinase be the missing link. [Cancer Invest. 2009]
Review Statins and breast cancer: may matrix metalloproteinase be the missing link.
Mannello F, Tonti GA. Cancer Invest. 2009 May; 27(4):466-70.
Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort. [J Natl Cancer Inst. 2006]
Cholesterol-lowering drugs and colorectal cancer incidence in a large United States cohort.
Jacobs EJ, Rodriguez C, Brady KA, Connell CJ, Thun MJ, Calle EE. J Natl Cancer Inst. 2006 Jan 4; 98(1):69-72.
Review Lipid-lowering therapy. New and established agents reduce risk of cardiovascular events. [Postgrad Med. 2004]
Review Lipid-lowering therapy. New and established agents reduce risk of cardiovascular events.
Smith CR Jr. Postgrad Med. 2004 Mar; 115(3):29-30, 33-6.
Review Influence of statins on MHC class I expression. [Ann N Y Acad Sci. 2009]
Review Influence of statins on MHC class I expression.
Singh P, Kohr D, Kaps M, Blaes F. Ann N Y Acad Sci. 2009 Sep; 1173:746-51.

See reviews... See all...

Cited by 17 PubMed Central articles

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors. [PLoS One. 2012]
Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors.
Mostaghel EA, Solomon KR, Pelton K, Freeman MR, Montgomery RB. PLoS One. 2012; 7(1):e30062. Epub 2012 Jan 18.
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. [PLoS One. 2012]
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy.
Cholesterol Treatment Trialists' (CTT) Collaboration, Emberson JR, Kearney PM, Blackwell L, Newman C, Reith C, Bhala N, Holland L, Peto R, Keech A, et al. PLoS One. 2012; 7(1):e29849. Epub 2012 Jan 19.
The role of lipid rafts in cancer cell adhesion and migration. [Int J Cell Biol. 2012]
The role of lipid rafts in cancer cell adhesion and migration.
Murai T. Int J Cell Biol. 2012; 2012:763283. Epub 2011 Dec 29.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Do the cholesterol-lowering properties of statins affect cancer risk?
Do the cholesterol-lowering properties of statins affect cancer risk?
Trends Endocrinol Metab. 2008 May-Jun ;19(4):113-21. Epub 2008 Mar 20 .

PubMed
Clathrin dependence of synaptic-vesicle formation at the Drosophila neuromuscula...
Clathrin dependence of synaptic-vesicle formation at the Drosophila neuromuscular junction.
Curr Biol. 2008 Mar 25 ;18(6):401-9.

PubMed
Chromatophore genome sequence of Paulinella sheds light on acquisition of photos...
Chromatophore genome sequence of Paulinella sheds light on acquisition of photosynthesis by eukaryotes.
Curr Biol. 2008 Mar 25 ;18(6):410-8.

PubMed
Efficient phage-mediated pigment biosynthesis in oceanic cyanobacteria.
Efficient phage-mediated pigment biosynthesis in oceanic cyanobacteria.
Curr Biol. 2008 Mar 25 ;18(6):442-8.

PubMed
Audio-visual recording of patient-GP consultations for research purposes: a lite...
Audio-visual recording of patient-GP consultations for research purposes: a literature review on recruiting rates and strategies.
Patient Educ Couns. 2008 May ;71(2):157-68. Epub 2008 Mar 19 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: